IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
98.15
-0.15 (-0.15%)
At close: Jan 6, 2026, 4:00 PM EST
98.07
-0.08 (-0.08%)
After-hours: Jan 6, 2026, 4:10 PM EST
IRADIMED CORPORATION Market Cap
IRADIMED CORPORATION has a market cap or net worth of $1.25 billion as of January 6, 2026. Its market cap has increased by 85.88% in one year.
Market Cap
1.25B
Enterprise Value
1.19B
1-Year Change
85.88%
Ranking
Category
Stock Price
$98.15
Market Cap Chart
Since July 16, 2014, IRADIMED CORPORATION's market cap has increased from $100.50M to $1.25B, an increase of 1,142.37%. That is a compound annual growth rate of 24.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 1.25B | 1.05% |
| Dec 31, 2025 | 1.24B | 77.55% |
| Dec 31, 2024 | 697.00M | 16.48% |
| Dec 29, 2023 | 598.40M | 68.33% |
| Dec 30, 2022 | 355.50M | -37.66% |
| Dec 31, 2021 | 570.30M | 103.90% |
| Dec 31, 2020 | 279.70M | 4.17% |
| Dec 31, 2019 | 268.50M | 0.37% |
| Dec 31, 2018 | 267.50M | 67.29% |
| Dec 29, 2017 | 159.90M | 34.48% |
| Dec 30, 2016 | 118.90M | -61.68% |
| Dec 31, 2015 | 310.30M | 122.44% |
| Dec 31, 2014 | 139.50M | 38.81% |
| Jul 16, 2014 | 100.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 947.23B |
| Johnson & Johnson | 495.59B |
| AbbVie | 392.55B |
| UnitedHealth Group | 317.45B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.19B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |